ArticleClinical medicine (London, England)2020
Epilepsy care in the COVID-19 era.
Article in Clinical medicine (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- The impact of COVID-19 on people with epilepsy: Global results from the coronavirus and epilepsy study.Epilepsia open · 2024Article
- Epilepsy-related mortality during the COVID-19 pandemic: A nationwide study of routine Scottish data.Seizure · 2023Article
- Trends in outpatient and inpatient visits for separate ambulatory-care-sensitive conditions during the first year of the COVID-19 pandemic: a province-based study.Frontiers in public health · 2023Article
- Impact of the COVID-19 pandemic on people with epilepsy: findings from the US arm of the COV-E study.Epilepsia open · 2022Article
- Practical guidance for telemedicine use in neuro-oncology.Neuro-oncology practice · 2022Review
- COVID-19 pandemic influence on epilepsy course in pediatric patients.Epilepsy & behavior : E&B · 2022Article
- Evaluation of telemedicine for new outpatient neurological consultations.BMJ neurology open · 2022Article
- Conceptualization and implementation of an interdisciplinary clinic for children with drug-resistant epilepsy during the COVID-19 pandemic.Epilepsy & behavior : E&B · 2021Article
- Impact of the COVID-19 pandemic on people with epilepsy: Findings from the Brazilian arm of the COV-E study.Epilepsy & behavior : E&B · 2021Article
- Epilepsy surgery in COVID times-a unique conundrum.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2021Article
- Medium-term effects of COVID-19 pandemic on epilepsy: A follow-up study.Acta neurologica Scandinavica · 2021Article
- Epilepsy care and COVID-19: A cross-sectional online survey from Lithuania.Acta neurologica Scandinavica · 2021Article
- The impact of the coronavirus disease (COVID-19) pandemic on outpatient epilepsy care: An analysis of physician practices in Germany.Epilepsy & behavior : E&B · 2021Article
- Impact of COVID-19 on the lives and psychosocial well-being of persons with epilepsy during the third trimester of the pandemic: Results from an international, online survey.Epilepsy & behavior : E&B · 2021Article
- Responses of people with epilepsy to the COVID-19 pandemic in the time of national lockdown.Epilepsy & behavior : E&B · 2021Article
- Article
- The Effects of the Health System Response to the COVID-19 Pandemic on Chronic Disease Management: A Narrative Review.Risk management and healthcare policy · 2021Review
- Telehealth for Children With Epilepsy Is Effective and Reduces Anxiety Independent of Healthcare Setting.Frontiers in pediatrics · 2021Article
- COVID-19 containment and its unrestrained impact on epilepsy management in resource-limited areas of Pakistan.Epilepsy & behavior : E&B · 2020Article
- The diagnosis of epilepsy in the COVID-19 era: Dealing with revolution in clinical practice.Epilepsy & behavior : E&B · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 pandemic will impact on how care for chronic conditions is delivered. We use epilepsy to exemplify how care for patients will be affected, and suggest ways in which healthcare systems can respond to deliver the most effective care. Where face-to-face outpatient appointments have been cancelled, telemedicine can facilitate remote clinical consultations for new and follow-up epilepsy clinic patients while reducing the risk of infection to both patients and healthcare staff. First-seizure patients will need investigation pathways rationalised, while those with chronic epilepsy will need to have reliable alternative avenues to access clinical advice. At the same time, neurologists should support emergency departments and acute medical units, advising on appropriate management of seizures and other acute neurological presentations. Ultimately, the revolution in our clinical practice is unlikely to cease after this pandemic, with reconfiguration of services likely to bring improvements in efficiency and convenience, and a reduced environmental impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.